Boston Scientific (NYSE:BSX) today reported first-quarter financial results that came in ahead of the Wall Street forecast.
On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech ...
April 22 () - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a ...
Boston Scientific Corp. BSX shares are in the spotlight on Tuesday after Stifel maintained a Buy rating and lowered its price ...
Boston Scientific stock rallied Wednesday despite cutting its 2026 outlook. An analyst says this could offer a reset for shares.
Author Rachel Zoffness breaks down why we have chronic pain and how science shows that it’s all in our head ...
Despite Boston’s Q1 performance denoting a YoY rise of 11.2%, the company has trimmed its full-year growth outlook by 2% at the top-end.
Made Scientific, Inc., a U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Regenicin, ...
AI has already proved itself a valuable scientific tool. Could it take on a more central role in the research process?